indazoles has been researched along with cd 437 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belzacq, AS; Brenner, C; Cohen, I; El Hamel, C; Haouzi, D; Kroemer, G; Marchetti, P; Métivier, D; Vieira, HL | 1 |
| Amoroso, R; Bartoli, B; Benvenuti, L; Gagliardi, R; Gremigni, V; Lena, A; Rechichi, M; Rossi, L; Salvetti, A; Scarcelli, V; Vecchio, D | 1 |
2 other study(ies) available for indazoles and cd 437
| Article | Year |
|---|---|
Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437.
Topics: Antineoplastic Agents; Apoptosis; Arsenites; Cell Membrane Permeability; Cytomegalovirus; HeLa Cells; Humans; Immediate-Early Proteins; Indazoles; Intracellular Membranes; Jurkat Cells; Mitochondria; Mitochondrial ADP, ATP Translocases; Retinoids; Viral Proteins | 2001 |
Drugs targeting the mitochondrial pore act as cytotoxic and cytostatic agents in temozolomide-resistant glioma cells.
Topics: Acridine Orange; Betulinic Acid; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Death; Cell Line, Tumor; Cell Survival; Cyclosporine; Cytostatic Agents; Dacarbazine; Drug Resistance, Neoplasm; ErbB Receptors; Glioma; Humans; Indazoles; Membrane Potential, Mitochondrial; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Pentacyclic Triterpenes; Polymerase Chain Reaction; Retinoids; Temozolomide; Triterpenes | 2009 |